Life Sciences/Biotech

Assay Designs, VWR International Sign Distribution Agreement

ANN ARBOR - Assay Designs, a provider of immunoassay kits, antibodies, and reagents to the life sciences and translational research markets, and VWR International, a distributor of scientific equipment, supplies, chemicals, and furniture, announced a new distribution agreement - VWR will offer North American customers a variety of Assay Designs' products. Customers will immediately be

By |2007-07-24T00:00:00-04:00July 24th, 2007|Archive, Life Sciences/Biotech|

Van Andel Institute Researcher Furthers Prostate Cancer Therapy

GRAND RAPIDS ? Scientific Investigator Cindy Miranti, Ph.D. and her team in the Laboratory of Integrin Signaling and Tumorigenesis at Van Andel Research Institute have discovered that an enzyme that prostate cancer cells are dependent on for survival is not necessary in normal prostate cells. This finding validates the therapeutic potential of targeting this enzyme

By |2007-07-19T00:00:00-04:00July 19th, 2007|Archive, Life Sciences/Biotech|

Ted Heilman Named Investment Director At Van Andel Institute

GRAND RAPIDS ? Ted Heilman has joined Van Andel Institute as Assistant Director, Investments ? Senior Portfolio Manager. In this newly created position, he assists with the management of the Institute?s endowment. Heilman worked previously as senior portfolio manager and head of portfolio management in the Wealth Management Group at Fifth Third Bank, where he

By |2007-07-16T00:00:00-04:00July 16th, 2007|Archive, Life Sciences/Biotech|

MichBio Expo Set For October At Lansing Center

ANN ARBOR ? Life sciences trade association MichBio will host the MichBio Expo on October 16 and 17 at the Lansing Center and feature James Greenwood, CEO of the Biotechnology Industry Organization, as its opening keynote speaker. Based in Washington, D.C., BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related

By |2007-07-16T00:00:00-04:00July 16th, 2007|Archive, Life Sciences/Biotech|

JHP Pharma To Buy King Sterile Plant In Rochester For $90 Million

ROCHESTER ? JHP Pharmaceuticals will purchase the sterile manufacturing facility of King Pharmaceuticals in Rochester, some of King?s current products manufactured there and related contract manufacturing business for $90 million, subject to final inventory adjustments. The companies also entered into a manufacturing and supply agreement pursuant to which JHP will provide certain fill and finish

By |2007-07-16T00:00:00-04:00July 16th, 2007|Archive, Life Sciences/Biotech|

Wanted: Michigan Life Sciences, Medical Device CEOs To Join Roundtable

BLOOMFIELD HILLS - CJPS Enterprises, through a contract from the Michigan Economic Development Corporation, will be inviting a few select medical device and life sciences executives to join its Chief Executives Roundtable. The group will be comprised of CEOs, executive directors, general managers, and business owners interested in growing their medical device or life science

By |2006-12-19T00:00:00-05:00December 19th, 2006|Archive, Life Sciences/Biotech|

Michigan Needs To Create Economic Climate To Foster Biotech Growth

LANSING ? At a forum in Lansing Tuesday, leading experts pounded home this point - Michigan needs to create an environment that fosters economic growth for the state's biotech and life science industry that helps all companies, regardless of size, succeed. The forum brought together biotechnology executives, venture capitalists, academicians, policymakers and business leaders from

By |2006-12-12T00:00:00-05:00December 12th, 2006|Archive, Life Sciences/Biotech|

Pfizer To Cut US Sales Force By 20 Percent

NEW YORK - Pfizer Inc. unveiled plans Tuesday to reduce its U.S. sales organization by about 20 percent, an acknowledgement that its current model for marketing drugs to doctors has become too expensive. The company said that despite the cuts, it would maintain "strong support" for big sellers Lipitor and Celebrex, as well as for

By |2006-11-28T00:00:00-05:00November 28th, 2006|Archive, Life Sciences/Biotech|

Aastrom Biosciences Big Losses Continue Due To Clinical Trials Expenses

ANN ARBOR ? Higher expenses due to ongoing clinical trials in the U.S. and Europe, plus added costs for building a new manufacturing facility and paying a severance package to the former CEO, added to the quarterly losses at Aastrom Biosciences. The pharma company, which is developing cells to regenerate growth, lost $4 million for

By |2006-11-14T00:00:00-05:00November 14th, 2006|Archive, Life Sciences/Biotech|

Neogen, Niowave Get Housing Assistance Incentives From State

LANSING ? Neogen Corp. and Niowave will get housing assistance incentives from the Michigan State Housing Development Authority to offer special mortgages and other financial incentives to recruit new employees. The Employer Assisted Housing program at MSHDA helps employers create their own housing benefit program and brings a zero-interest down payment loan of up to

By |2006-11-14T00:00:00-05:00November 14th, 2006|Archive, Life Sciences/Biotech|